Clinical Trial

Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.

Study acronym: DOSIPROSTATE
Recruiting
View on ClinicalTrials.gov →
Summary
Single-centre, retrospective and prospective observational study. This study aims to evaluate the dose delivered by radiation to the tumour and organs at risk, as a factor predicting response and the appearance of toxicities. Dosimetric calculations are made for each treatment using scintigraphic images acquired following injection of 177Lu-PSMA-617.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-19.
Trial Details
NCT Number NCT06700057
Lead Sponsor Institut Bergonié
Conditions Prostate Cancer, Metastasis
Enrollment 50 participants
Start Date 2023-11-01
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-30